Evidence map›Paper›PMID 33243861›Full record

ArticleScience (New York, N.Y.)2020

In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes.

Xin Jin, Sean K Simmons, Amy Guo, Ashwin S Shetty, Michelle Ko, Lan Nguyen, Vahbiz Jokhi, Elise Robinson, Paul Oyler, Nathan Curry and 6 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 3 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 3 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Mapping the dialogue: Decoding alveolar stem-niche interactions.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. ScalablebioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Xin JinSociety of Fellows, Harvard University, Cambridge, MA, USA. xinjin@fas.harvard.edu aregev@broadinstitute.org zhang@broadinstitute.org paola_arlotta@harvard.edu.ORCID 0000-0003-2344-992X
Sean K SimmonsBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Amy GuoBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Ashwin S ShettyDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.ORCID 0000-0002-2812-7674
Michelle KoDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.
Lan NguyenBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Vahbiz JokhiDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.
Elise RobinsonBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Paul OylerDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.ORCID 0000-0002-3141-0980
Nathan CurryDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.
Giulio DeangeliDepartment of Stem Cell and Regenerative Biology, Harvard University, MA, USA.
Simona LodatoDepartment of Biomedical Sciences and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.ORCID 0000-0001-6498-2590
Joshua Z LevinBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-0170-3598
Aviv Regev *Broad Institute of MIT and Harvard, Cambridge, MA, USA. xinjin@fas.harvard.edu aregev@broadinstitute.org zhang@broadinstitute.org paola_arlotta@harvard.edu.ORCID 0000-0003-3293-3158
Feng Zhang *Broad Institute of MIT and Harvard, Cambridge, MA, USA. xinjin@fas.harvard.edu aregev@broadinstitute.org zhang@broadinstitute.org paola_arlotta@harvard.edu.ORCID 0000-0003-0178-7995
Paola Arlotta *Department of Stem Cell and Regenerative Biology, Harvard University, MA, USA. xinjin@fas.harvard.edu aregev@broadinstitute.org zhang@broadinstitute.org paola_arlotta@harvard.edu.ORCID 0000-0003-2184-2277
Broad Institute · USHarvard University · USHumanitas University · IT

Funding

Genetic neuroscience: How human genes and alleles shape neuronal phenotypesU01MH115727 · NIMH · BROAD INSTITUTE, INC. · PI ARLOTTA, PAOLA, BABADI, MEHRTASH · 2017 to 2021
$20.8M
Res Support CoreP50MH094271 · NIMH · HARVARD UNIVERSITY · PI HENSCH, TAKAO K · 2011 to 2022
$18.6M
Programmable RNA-targeting toolsR01HG009761 · NHGRI · BROAD INSTITUTE, INC. · PI ZHANG, FENG · 2017 to 2024
$7.5M
Exploration of Diverse Mobile Genetic Elements for Precision Genome ManipulationDP1HL141201 · NHLBI · BROAD INSTITUTE, INC. · PI ZHANG, FENG · 2017 to 2021
$6.2M
Novel epigenetic mechanisms in neuronal development and cognitive functionR01MH096066 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI ARLOTTA, PAOLA, POMEROY, SCOTT LOREN · 2012 to 2022
$6.1M
Massively-parallel functional interrogation of psychiatric geneticsR01MH110049 · NIMH · BROAD INSTITUTE, INC. · PI ZHANG, FENG · 2015 to 2019
$5.5M
Howard Hughes Medical InsititueNHGRI NIH HHS R01 HG009761NHLBI NIH HHS DP1 HL141201NIMH NIH HHS P50 MH094271NIMH NIH HHS R01 MH096066NIMH NIH HHS R01 MH110049NIMH NIH HHS U01 MH115727
6 · The paper itself

Abstract

The number of disease risk genes and loci identified through human genetic studies far outstrips the capacity to systematically study their functions. We applied a scalable genetic screening approach, in vivo Perturb-Seq, to functionally evaluate 35 autism spectrum disorder/neurodevelopmental delay (ASD/ND) de novo loss-of-function risk genes. Using CRISPR-Cas9, we introduced frameshift mutations in these risk genes in pools, within the developing mouse brain in utero, followed by single-cell RNA-sequencing of perturbed cells in the postnatal brain. We identified cell type-specific and evolutionarily conserved gene modules from both neuronal and glial cell classes. Recurrent gene modules and cell types are affected across this cohort of perturbations, representing key cellular effects across sets of ASD/ND risk genes. In vivo Perturb-Seq allows us to investigate how diverse mutations affect cell types and states in the developing organism.

Indexed as

AnimalsAnkyrinsAutistic DisorderBrainCRISPR-Cas SystemsDNA-Binding ProteinsFrameshift MutationGene Expression ProfilingGenetic LociHumansMiceNeurogliaNeuronsRepressor ProteinsRiskTranscription FactorsANK2 protein, humanAnkyrinsCHD8 protein, humanDNA-Binding ProteinsGATAD2A protein, humanRepressor ProteinsTranscription Factors

Identifiers

PMID33243861
PMCPMC7985844
OpenAlexW3110610967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.